CN108640921B - 一种枸橼酸托法替布的制备方法 - Google Patents
一种枸橼酸托法替布的制备方法 Download PDFInfo
- Publication number
- CN108640921B CN108640921B CN201810289253.3A CN201810289253A CN108640921B CN 108640921 B CN108640921 B CN 108640921B CN 201810289253 A CN201810289253 A CN 201810289253A CN 108640921 B CN108640921 B CN 108640921B
- Authority
- CN
- China
- Prior art keywords
- tofacitinib
- methyl
- pyrrolo
- amine
- crude product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
时间(min) | 流动相A(%) | 流动相B(%) |
0.01 | 85 | 15 |
10.0 | 80 | 20 |
20.0 | 80 | 20 |
30.0 | 55 | 45 |
39.0 | 55 | 45 |
39.1 | 85 | 15 |
55.0 | 85 | 15 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810289253.3A CN108640921B (zh) | 2018-04-03 | 2018-04-03 | 一种枸橼酸托法替布的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810289253.3A CN108640921B (zh) | 2018-04-03 | 2018-04-03 | 一种枸橼酸托法替布的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108640921A CN108640921A (zh) | 2018-10-12 |
CN108640921B true CN108640921B (zh) | 2022-07-08 |
Family
ID=63745513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810289253.3A Active CN108640921B (zh) | 2018-04-03 | 2018-04-03 | 一种枸橼酸托法替布的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108640921B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110003220B (zh) * | 2019-05-07 | 2021-01-01 | 江苏永安制药有限公司 | 一种枸橼酸托法替布的制备方法 |
CN112697906B (zh) * | 2020-12-10 | 2022-09-13 | 上海博悦生物科技有限公司 | 一种检测托法替布手性中间体及其对映异构体的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2938616A4 (en) * | 2012-12-28 | 2016-06-15 | Glenmark Pharmaceuticals Ltd | PROCESS FOR THE PREPARATION OF TOFACITINIB AND INTERMEDIATES |
CN103585126A (zh) * | 2013-11-18 | 2014-02-19 | 南京艾德凯腾生物医药有限责任公司 | 一种托法替尼组合物及制备方法 |
CN106176640B (zh) * | 2014-11-28 | 2019-12-20 | 四川海思科制药有限公司 | 一种含枸橼酸托法替布的药物组合物及其制备方法 |
CN105348287A (zh) * | 2015-11-30 | 2016-02-24 | 宁波立华制药有限公司 | 一种枸橼酸托法替布的新型合成工艺 |
CN106146517B (zh) * | 2016-06-20 | 2018-08-28 | 山东大学 | 一种枸橼酸托法替尼的合成方法 |
CN106389371B (zh) * | 2016-11-16 | 2019-03-15 | 杭州朱养心药业有限公司 | 枸橼酸托法替布药物组合物 |
-
2018
- 2018-04-03 CN CN201810289253.3A patent/CN108640921B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108640921A (zh) | 2018-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7352587B2 (ja) | Krasg12c突然変異タンパク質阻害剤としてのピリドン-ピリミジン系誘導体 | |
EP3317289B1 (en) | Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection | |
US20220112177A1 (en) | Ketoamide compound and preparation method, pharmaceutical composition, and use thereof | |
EP2010505B1 (en) | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | |
EP3578561A1 (en) | Spiro compounds | |
US20240166610A1 (en) | Substituted pyridazine phenol derivatives | |
JP2001527058A (ja) | ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物 | |
JP2016537369A (ja) | カゼインキナーゼ1d/e阻害剤としての置換された4,5,6,7−テトラヒドロピラゾロ[1,5−a]ピラジン誘導体 | |
AU2022258377B2 (en) | Ring-modified proline short peptide compound and use thereof | |
JP7491896B2 (ja) | Pde3/pde4二重阻害剤としての融合三環式化合物 | |
AU2015366636A1 (en) | Pyrrolopyrimidine compound | |
CN108640921B (zh) | 一种枸橼酸托法替布的制备方法 | |
WO2014146494A1 (zh) | β-氨基羰基类化合物、其制备方法、药物组合物及其用途 | |
UA126847C2 (uk) | Дизаміщені піразольні сполуки як інгібітори кетогексокінази | |
WO2020263822A1 (en) | Selective btk irreversible inhibitors | |
CN108676009B (zh) | 作为her2酪氨酸激酶抑制剂的嘧啶衍生物及其应用 | |
JP2009534361A (ja) | ピログルタミン酸誘導体の合成および使用 | |
KR20180085814A (ko) | 치환된 5,6-디히드로-6-페닐벤조[f]이소퀴놀린-2-아민의 제조 방법 | |
JP2023512471A (ja) | Pde3/pde4二重阻害剤の結晶及びその使用 | |
CN105732659A (zh) | 硝基咪唑类化合物及其制备方法和在制药中的用途 | |
AU2009301797B2 (en) | Indazole derivative | |
WO2024067744A1 (zh) | 杂环取代喹唑啉及其制备方法和应用 | |
EP3753942B1 (en) | Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor | |
EP3498715A1 (en) | Anti-hcmv virus compound | |
CN108586341B (zh) | 酰胺类化合物和其药用盐及其制备方法和药物用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 2666 Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province Applicant after: Kexing biopharmaceutical Co.,Ltd. Address before: 250200 2666 Chuang Road, Ming Shui development area, Zhangqiu District, Ji'nan, Shandong. Applicant before: SHANDONG KEXING BIOPRODUCTS CO.,LTD. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ren Shiping Inventor after: Cui Ning Inventor after: Zhang Yun Inventor after: Liu Haimin Inventor after: Guo Chao Inventor before: Cui Ning Inventor before: Hao Zhihai Inventor before: Zhang Yun Inventor before: Liu Haimin Inventor before: Guo Chao Inventor before: Ren Shiping Inventor before: Wang Cuicui Inventor before: Qiu Duxian |
|
GR01 | Patent grant | ||
GR01 | Patent grant |